Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Entrotech life sciences

Entrotech life sciences?uq=w9if130k
2012 FOUNDED
PRIVATE STATUS
21-30 EMPLOYEES
Series B LATEST DEAL TYPE
$2.5M LATEST DEAL AMOUNT
Description

Developer of antimicrobial healthcare devices. The company specializes in developing and designing a chlorhexidine that can be utilized In any self-adhesive device or liquid delivery application.

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Other Devices and Supplies
Primary Office
  • 409 Illinois Street
  • San Francisco, CA 94158
  • United States
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Entrotech life sciences’s full profile, request a free trial.

Entrotech life sciences Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Early Stage VC (Series B) 08-Dec-2015 $2.5M 00.00 000.00 Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

Entrotech life sciences Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned
Series B 0,000,000 00.000000 00.0 00.00 00.00 00 00.00 0.000
Series A 0,000,000 00.000000 00.00 00.00 00.00 00 00.00 00.000
To view this company’s complete Cap Table, request access »

Entrotech life sciences Executive Team (2)

Name Title Board
Seat
Contact
Info
James McGuire Chief Executive Officer
John Halsey President